Trials / Sponsors / Henlix, Inc
Henlix, Inc
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Statu Solid Tumor, Adult | Phase 1 | 2020-03-03 |
| Unknown | Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients Hepatitis B, Chronic | Phase 2 | 2019-12-31 |
| Terminated | A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor- Solid Tumor, Adult | Phase 1 | 2018-03-22 |
| Unknown | Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced So Solid Tumor | Phase 1 | 2018-02-14 |
| Completed | An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Solid Tumour | Phase 1 | 2016-09-01 |